Amgen Inc
(AMGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,301,000 | 9,708,000 | 10,944,000 | 34,741,000 | 34,248,000 |
| Receivables | 6,934,000 | 6,776,000 | 7,268,000 | 6,145,000 | 5,830,000 |
| Inventories | 7,995,000 | 8,724,000 | 9,518,000 | 5,026,000 | 4,978,000 |
| Other current assets | 2,976,000 | 2,821,000 | 2,602,000 | 2,565,000 | 2,324,000 |
| TOTAL | $27,206,000 | $28,029,000 | $30,332,000 | $48,477,000 | $47,380,000 |
| Non-Current Assets | |||||
| PPE Net | 6,097,000 | 6,002,000 | 5,941,000 | 5,563,000 | 5,532,000 |
| Intangibles | 48,788,000 | 49,942,000 | 51,270,000 | 28,659,000 | 30,164,000 |
| Other Non-Current Assets | 8,816,000 | 9,007,000 | 9,611,000 | 7,835,000 | 7,193,000 |
| TOTAL | $63,701,000 | $64,951,000 | $66,822,000 | $42,057,000 | $42,889,000 |
| Total Assets | $90,907,000 | $92,980,000 | $97,154,000 | $90,534,000 | $90,269,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,528,000 | 3,959,000 | 1,443,000 | 1,428,000 | 2,167,000 |
| Accounts payable and accrued liabilities | 2,267,000 | 1,628,000 | 1,590,000 | 1,358,000 | 1,212,000 |
| Accrued Expenses | 13,722,000 | 14,127,000 | 15,359,000 | 14,168,000 | 13,718,000 |
| TOTAL | $21,517,000 | $19,714,000 | $18,392,000 | $16,954,000 | $17,097,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 57,117,000 | 60,061,000 | 63,170,000 | 59,040,000 | 59,377,000 |
| Other Non-Current Liabilities | 4,568,000 | 6,321,000 | 7,006,000 | 6,884,000 | 7,014,000 |
| TOTAL | $63,465,000 | $68,244,000 | $72,530,000 | $65,924,000 | $66,391,000 |
| Total Liabilities | $84,982,000 | $87,958,000 | $90,922,000 | $82,878,000 | $83,488,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 537,329 | 536,435 | 535,919 | 535,178 | 534,901 |
| Common Shares | 33,204,000 | 33,082,000 | 33,070,000 | 32,753,000 | 32,601,000 |
| Retained earnings | -27,124,000 | -27,870,000 | -26,549,000 | -24,971,000 | -25,540,000 |
| Other shareholders' equity | -155,000 | -190,000 | -289,000 | -126,000 | -280,000 |
| TOTAL | $5,925,000 | $5,022,000 | $6,232,000 | $7,656,000 | $6,781,000 |
| Total Liabilities And Equity | $90,907,000 | $92,980,000 | $97,154,000 | $90,534,000 | $90,269,000 |